Bohrer Denise, Do Nascimento Paulo Cícero, Ramirez Adrian G, Mendonça Jean Karlo A, De Carvalho Leandro M, Pomblum Solange Cristina G
Departamento de Químic Universidade Federal de Santa Maria, 97 105-900 Santa Maria, Brazil.
Clin Chim Acta. 2004 Jul;345(1-2):113-21. doi: 10.1016/j.cccn.2004.03.001.
The determination of the ratio free/protein-bound serum copper along with urinary copper can be used as a preliminary test for the Wilson's Disease diagnosis. In this work, the determination of these copper fractions in serum samples was carried out in two different ways; after separation of the copper bound to proteins from the free fraction by a column for protein adsorption and by ultrafiltration. As proteins can be adsorbed onto plastic polymeric surfaces, polyethylene (PE) with different molecular weights in powder form was investigated for protein adsorption. A small column was adapted in a flow system to carry out a solid-phase extraction (SPE) on-line. Preliminary experiments defined conditions for protein retention and elution and column saturation. Good performance was achieved using Mg(NO3)2 solution as carrier and methanol as eluent. The presence of proteins in both fraction (column effluent and eluate) was checked by the Coomassie Brilliant Blue test. Copper was measured by graphite furnace atomic absorption spectrometry. The measurement in the column effluent furnished the free-fraction of copper while the copper measured in the eluate the bound-fraction. The method was compared with ultrafiltration (20 kDa), measuring the free-copper in the ultrafiltrate. For the determination of protein-bound copper, the copper found in the ultrafitrate was discounted from the total copper measured in the sample.
Serum samples of 10 individuals were analyzed by both methods with good agreement of the results. The regression plots, obtained by analysing the samples by both methods, presented r2 and slope of 0.97 and 0.96 for free copper and 1.00 and 1.00 for bound copper, respectively. Protein-bound copper (PB) concentrations ranged from 74 to 2074 microg/l and free-copper (F) from 22 to 54 microg/l. The ratio F/PB, calculated from SPE data, was 29.7% for one individual, with Wilson Disease well-characterized, and ranged from 1.2% to 5.2% for the others.
The SPE method performed well in terms of accuracy and precision, and showed good agreement with the UF. Advantages of SPE are small sample volume (50 microl), separation carried out in 10 min, and the use of the same column for several analyses.
血清游离铜与蛋白结合铜的比值以及尿铜的测定可作为肝豆状核变性诊断的初步检测方法。在本研究中,采用两种不同方法测定血清样本中的这些铜组分;一种是通过蛋白质吸附柱将与蛋白结合的铜与游离组分分离,另一种是通过超滤。由于蛋白质可吸附在塑料聚合物表面,因此对不同分子量的粉末状聚乙烯(PE)进行了蛋白质吸附研究。在流动系统中改装了一个小柱以进行在线固相萃取(SPE)。初步实验确定了蛋白质保留、洗脱和柱饱和的条件。使用硝酸镁溶液作为载体和甲醇作为洗脱剂时取得了良好的效果。通过考马斯亮蓝试验检测两个组分(柱流出物和洗脱液)中蛋白质的存在情况。采用石墨炉原子吸收光谱法测定铜含量。柱流出物中的测量值提供了铜的游离组分,而洗脱液中测量的铜为结合组分。将该方法与超滤法(20 kDa)进行比较,通过测量超滤物中的游离铜来进行比较。对于蛋白结合铜的测定,从超滤物中测得的铜含量从样品中测得的总铜含量中扣除。
用两种方法对10名个体的血清样本进行分析,结果具有良好的一致性。通过两种方法分析样本得到的回归图显示,游离铜的r2和斜率分别为0.97和0.96,结合铜的r2和斜率分别为1.00和1.00。蛋白结合铜(PB)浓度范围为74至2074μg/l,游离铜(F)浓度范围为22至54μg/l。根据SPE数据计算得到的F/PB比值,对于一名确诊为肝豆状核变性的个体为29.7%,其他个体的比值范围为1.2%至5.2%。
SPE方法在准确性和精密度方面表现良好,与超滤法具有良好的一致性。SPE的优点是样本体积小(50μl)、10分钟内完成分离以及同一根柱子可用于多次分析。